Absence of mutations in the coding region of the α-synuclein gene in pathologically proven Parkinson's disease

Neurology

Volumn 50, Issue 4, 1998, Pages 1136-1137

  Chan, P ^a   Jiang, X ^a   Forno, L S ^b   Di Monte, D A ^a   Tanner, C M ^a   Langston, J W ^a  

^a PARKINSON S INSTITUTE   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; FEMALE; GENE SEQUENCE; GENETIC ANALYSIS; HUMAN; MALE; MISSENSE MUTATION; PARKINSON DISEASE; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

EID: 0031900214     PISSN: 00283878     EISSN: None     Source Type: Journal    
DOI: 10.1212/WNL.50.4.1136     Document Type: Article

References (8)

1. Spillantini MG, Schmidt ML, Lee VMY, Trojanowski JQ, Jakes R, Goedert M. α-Synuclein in Lewy bodies. Nature 1997;388:839-840.
2. Polymeropoulos MH, Lavedan C, Leroy E, et al. Mutation in the α-synuclein gene identified in families with Parkinson's disease. Science 1997;276:2045-2047.
3. Golbe LI, Di Iorio G, Sanges G, et al. Clinical genetic analysis of Parkinson's disease in the Contursi kindred. Ann Neurol 1996;40:767-775.
4. Forno LS, Langston JW. Lewy bodies and aging: relation to Alzheimer's and Parkinson's diseases. Neurodegeneration 1993;2:19-24.
5. Iwai A, Masliah E, Yoshimoto M, et al. The precursor protein of non-A beta component of Alzheimer's disease amyloid is a presynaptic protein of the central nervous system. Neuron 1995;14:467-475.
6. Ueda K, Fukushima H, Masliah E, et al. Molecular cloning of cDNA encoding an unrecognized component of amyloid in Alzheimer disease. Proc Natl Acad Sci USA 1993;90:11282-11286.
7. 209A) in 100 patients with younger onset Parkinson's disease. Neurology 1998;50:513-514.
8. Hughes AJ, Ben-Shlomo Y, Daniel SE, Lees AJ. What features improve the accuracy of clinical diagnosis in Parkinson's disease: a clinicopathologic study. Neurology 1992;42: 1142-1146.